Baudax Bio: Funding, Investors & Team (Sep 2026)
Baudax Bio is a specialty pharmaceutical company that generates revenue by developing and selling innovative products for acute care settings. They have multiple non-opioid therapies in development for treating pain conditions and are currently promoting their main product, ANJESO™, which is used for managing moderate-to-severe pain in adults. The company also has other early-stage products, including two new neuromuscular blocker agents and a chemical reversal agent, as well as Dex-IN, an intranasal formulation of dexmedetomidine, a drug with sedative, analgesic, and anxiolytic properties. Baudax Bio believes that its strong pipeline of products can benefit both patients and shareholders. Furthermore, they are actively exploring acquisition and licensing opportunities that align with their focus on acute care.
Baudax Bio has raised $1.9M across 1 funding round on record, the most recent an undisclosed round of $1.9M announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Baudax Bio Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Baudax Bio Funding Rounds
Baudax Bio Founders and Leadership Team
Contact details for the Baudax Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Baudax Bio Funding Compared to Other Biotechnology Startups
Baudax Bio's latest round of $1.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Baudax Bio in Biotechnology and Malvern
Companies Similar to Baudax Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Baudax Bio Funding FAQs
What does Baudax Bio do?
Baudax Bio is a specialty pharmaceutical company that generates revenue by developing and selling innovative products for acute care settings. They have multiple non-opioid therapies in development for treating pain conditions and are currently promoting their main product, ANJESO™, which is used for managing moderate-to-severe pain in adults. The company also has other early-stage products, including two new neuromuscular blocker agents and a chemical reversal agent, as well as Dex-IN, an intranasal formulation of dexmedetomidine, a drug with sedative, analgesic, and anxiolytic properties. Baudax Bio believes that its strong pipeline of products can benefit both patients and shareholders. Furthermore, they are actively exploring acquisition and licensing opportunities that align with their focus on acute care.
How much funding has Baudax Bio raised?
Baudax Bio has raised $1.9M across 1 round on record. The most recent is an undisclosed round of $1.9M announced in Aug 2023.
When did Baudax Bio last raise funding?
Baudax Bio's most recent funding round on record is an undisclosed round of $1.9M, announced in Aug 2023.
Who founded Baudax Bio?
FundedIQ lists Janice Trulli (Founder) at Baudax Bio.
Where is Baudax Bio headquartered?
Baudax Bio is based in Malvern, Pennsylvania, United States.
How many employees does Baudax Bio have?
Baudax Bio is in the 51-100 employee band.
How does Baudax Bio's funding compare to other Biotechnology startups?
Baudax Bio's latest round of $1.9M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Baudax Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Baudax Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.